SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-13-031234
Filing Date
2013-05-23
Accepted
2013-05-23 10:56:02
Documents
1
Group Members
L&L TECHNOLOGIES, LLCLEDER LABORATORIES, INC.LEDERMAN & CO., LLCSTARLING PHARMACEUTICALS, INC.TARGENT PHARMACEUTICALS, LLC

Document Format Files

Seq Description Document Type Size
1 SCHED 13D v346040_sc13d.htm SC 13D 189038
  Complete submission text file 0001144204-13-031234.txt   190618
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Subject) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86436 | Film No.: 13866984
SIC: 1000 Metal Mining

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
LEDERMAN SETH (Filed by) CIK: 0001563420 (see all company filings)

Type: SC 13D